Kimberly-Clark Broadens Device Stable Via $764 Mil. Ballard Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Kimberly-Clark's $764 mil. Ballard Medical Products buy expands the firm's disposable product line and signals a further diversification of the conglomerate's growing portfolio of medical device products.
You may also be interested in...
Kimberly-Clark Enters $3 Bil. Glove Market Via $850 Mil. Safeskin Buy
Acquisition of disposable medical glove maker Safeskin marks Kimberly-Clark's entrance into the $3 bil. worldwide latex and synthetic glove market and will boost sales of the firm's professional health care segment to approximately $950 mil. in 2000.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”